425
Publications
76.5K
Citations
17
Authors
Taipei
Taiwan
Other names
Taiwan Braunsing Ingelheim Co., Ltd.
台灣百靈佳殷格翰股份有限公司
Boehringer Ingelheim (Taiwan) is a company institution in Taipei, Taiwan known for medicine, pharmacology, and pathology.
425
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 11.6K citations · Full text
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D. Anker, Javed Butler et al. · New England Journal of Medicine · 2020 · 4.7K citations · Full text
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.5K citations · Full text
Idarucizumab for Dabigatran Reversal
Charles V. Pollack, Paul A. Reilly, John W. Eikelboom et al. · New England Journal of Medicine · 2015 · 1.4K citations
Rows per page
1–5 of 425
17
| Publications | Citations | H-Index | |
|---|---|---|---|
HW Boehringer Ingelheim (Taiwan) | 40 | 443 | 6 |
ZŠ Boehringer Ingelheim (Taiwan) | 37 | 111 | 5 |
KT Boehringer Ingelheim (Taiwan) | 3 | 139 | 3 |
LW Boehringer Ingelheim (Taiwan) | 6 | 221 | 3 |
JN Boehringer Ingelheim (Taiwan) | 4 | 71 | 3 |
Rows per page
1–5 of 17